West Pharmaceutical [WST] vs Hologic [HOLX] Detailed Stock Comparison

West Pharmaceutical Services Inc.

NYSE
Loading...

Hologic Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: West Pharmaceutical Services Inc. wins in 9 metrics, Hologic Inc. wins in 11 metrics, with 0 ties. Hologic Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric West Pharmaceutical Services Inc. Hologic Inc. Better
P/E Ratio (TTM) 40.99 31.54 Hologic Inc.
Price-to-Book Ratio 6.94 3.23 Hologic Inc.
Debt-to-Equity Ratio 10.73 48.05 West Pharmaceutical Services Inc.
PEG Ratio 0.74 -3.92 West Pharmaceutical Services Inc.
EV/EBITDA 24.63 12.68 Hologic Inc.
Profit Margin (TTM) 16.85% 13.18% West Pharmaceutical Services Inc.
Operating Margin (TTM) 21.70% 22.99% Hologic Inc.
EBITDA Margin (TTM) 21.70% 22.99% Hologic Inc.
Return on Equity 19.13% 10.86% West Pharmaceutical Services Inc.
Return on Assets (TTM) 11.21% 7.43% West Pharmaceutical Services Inc.
Free Cash Flow (TTM) $468.90M $904.70M Hologic Inc.
Dividend Yield 0.46% N/A N/A
1-Year Return 48.18% 31.39% West Pharmaceutical Services Inc.
Price-to-Sales Ratio (TTM) 6.72 4.11 Hologic Inc.
Enterprise Value $21.43B $17.12B West Pharmaceutical Services Inc.
EV/Revenue Ratio 6.65 4.15 Hologic Inc.
Gross Profit Margin (TTM) 35.08% 55.96% Hologic Inc.
Revenue per Share (TTM) $45 $18 West Pharmaceutical Services Inc.
Earnings per Share (Diluted) $7.47 $2.41 West Pharmaceutical Services Inc.
Beta (Stock Volatility) 1.15 0.70 Hologic Inc.
Short % of Float 4.38% 3.66% Hologic Inc.

West Pharmaceutical Services Inc. vs Hologic Inc. Stock Performance Analysis

Loading Price Chart...

WST
HOLX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
West Pharmaceutical Services Inc.0.79%3.65%9.42%37.92%21.91%19.91%
Hologic Inc.0.00%0.56%0.56%1.40%12.23%1.94%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
West Pharmaceutical Services Inc.48.18%-9.18%-6.66%345.01%1,441.58%1,794.12%
Hologic Inc.31.39%-9.66%-0.85%110.15%246.29%206.74%

Performance & Financial Health Analysis: West Pharmaceutical Services Inc. vs Hologic Inc.

MetricWSTHOLX
Market Information
Market Cap i$22.07B$16.97B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,085,83012,273,085
90 Day Avg. Volume i930,3276,282,625
Last Close$331.43$76.01
52 Week Range$206.80 - $336.82$51.90 - $76.07
% from 52W High-1.60%-0.08%
All-Time High$475.35 (Sep 06, 2021)$87.88 (May 01, 2023)
% from All-Time High-30.28%-13.51%
Growth Metrics
Quarterly Revenue Growth0.21%0.03%
Quarterly Earnings Growth0.55%-0.11%
Financial Health
Profit Margin (TTM) i0.17%0.13%
Operating Margin (TTM) i0.22%0.23%
Return on Equity (TTM) i0.19%0.11%
Debt to Equity (MRQ) i10.7348.05
Cash & Liquidity
Book Value per Share (MRQ)$44.11$23.51
Cash per Share (MRQ)$7.38$10.60
Operating Cash Flow (TTM) i$715.30M$1.10B
Levered Free Cash Flow (TTM) i$275.66M$848.61M
Dividends
Last 12-Month Dividend Yield i0.46%N/A
Last 12-Month Dividend i$1.07N/A

Valuation & Enterprise Metrics Analysis: West Pharmaceutical Services Inc. vs Hologic Inc.

MetricWST (Apr 26, 2026)HOLX (Apr 19, 2026)
Price Ratios
P/E Ratio (TTM) i40.9931.54
Forward P/E i32.0515.64
PEG Ratio i0.74-3.92
Price to Sales (TTM) i6.724.11
Price to Book (MRQ) i6.943.23
Market Capitalization
Market Capitalization i$22.07B$16.97B
Enterprise Value i$21.43B$17.12B
Enterprise Value Metrics
Enterprise to Revenue i6.654.15
Enterprise to EBITDA i24.6312.68
Risk & Other Metrics
Beta i1.150.70
Book Value per Share (MRQ) i$44.11$23.51

Financial Statements Comparison: West Pharmaceutical Services Inc. vs Hologic Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricWST (2025)HOLX (2025)
Revenue/Sales i3.07B4.10B
Cost of Goods Sold i1.97B1.98B
COGS % of Revenue i64.1%48.4%
Gross Profit i1.10B2.12B
Gross Margin i35.9%51.6%
Research & Development i74.30M248.20M
Operating Income (EBIT) i636.10M785.40M
Operating Margin i20.7%19.2%
EBITDA i822.70M1.17B
EBITDA Margin i26.8%28.5%
Pre-Tax Income i600.90M681.20M
Pre-Tax Income % of Revenue i19.5%16.6%
Income Tax i121.60M115.50M
Income Tax % of Revenue i4.0%2.8%
Net Income (Profit) i493.70M565.70M
Profit Margin i16.1%13.8%

Balance Sheet & Liquidity Metrics

MetricWST (2025)HOLX (2025)
Cash & Equivalents i791.30M1.96B
Total Current Assets i1.98B3.67B
Total Current Assets % of Revenue i64.4%89.5%
Total Current Liabilities i654.90M977.20M
Total Current Liabilities % of Revenue i21.3%23.8%
Long-Term Debt i298.40M2.59B
Long-Term Debt % of Revenue i9.7%63.2%
Total Shareholders Equity i3.18B5.05B
Retained Earnings i4.37B3.41B
Retained Earnings % of Revenue i142.3%83.2%
Property, Plant & Equipment i296.40M1.07B

Cash Flow Statement Comparison

MetricWST (2025)HOLX (2025)
Operating Cash Flow i753.00M831.50M
Operating Cash Flow % of Revenue i24.5%20.3%
Capital Expenditures iN/A-78.20M
Free Cash Flow i468.90M904.70M
FCF Margin i15.3%22.1%
Debt Repayment i-1.10M-1.20B
Common Stock Repurchase i-136.80M-752.90M

Short Interest & Institutional Ownership Analysis

MetricWSTHOLX
Shares Short i2.66M7.10M
Short Ratio i3.182.78
Short % of Float i4.38%3.66%
Shares Outstanding i70.90M223.07M
Float Shares i70.15M221.21M
% Held by Insiders i0.64%0.84%
% Held by Institutions i99.21%96.52%
% Held by Public i0.15%2.64%

Dividend Analysis & Yield Comparison: West Pharmaceutical Services Inc. vs Hologic Inc.

MetricWSTHOLX
Last 12-Month Dividend i$1.07N/A
Last 12-Month Dividend Yield i0.46%N/A
3-Year Avg Annual Dividend i$0.82N/A
3-Year Avg Dividend Yield i0.07%N/A
3-Year Total Dividends i$2.46N/A
Ex-Dividend DateJan 28, 2026N/A